Arca
Skip to content

Prader-willi syndrome

Drug research and approvals for prader-willi syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 14 studies of prader-willi syndrome are recruiting on ClinicalTrials.gov, Health Canada has authorized 7 drug trials for it since 2013, and FDA has 2 approved and 15 open orphan designations naming it.

  • Recruiting worldwide: 14
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 2
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 14 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Oct 24, 2025A phase 3, randomized, double-blind, placebo-controlled study of ard-101 for the treatment of hyperphagia in patients with prader -willi syndromeARD-101AARDVARK THERAPEUTICS INCClosed
Apr 24, 2025A phase 3, randomized, double-blind, placebo-controlled, efficacy and safety study of pitolisant followed by an open-label extension in patients with…PITOLISANT (HBS-101)HARMONY BIOSCIENCES MANAGEMENT, INC.Ongoing
Sep 14, 2023A long-term, open-label extension study of carbetocin nasal spray for the treatment of hyperphagia in prader-willi syndromeCARBETOCIN (ACP-101)ACADIA PharmaceuticalsClosed
Sep 14, 2023A phase 3, randomized, double-blind, placebo-controlled, parallel-group study of carbetocin nasal spray for the treatment of hyperphagia in prader-willi…CARBETOCIN (ACP-101)ACADIA PharmaceuticalsClosed
May 26, 2022A phase 2/3, randomized, double-blind, placebo-controlled study of rad011 (cannabidiol oral solution) for the treatment of patients with prader-willi syndromeCANNABIDIOL (RAD011)Radius PharmsPending
Dec 7, 2018Phase 3, randomized, double-blind, placebo-controlled, 8-week clinical study to assess the efficacy, safety, and tolerability, of intranasal carbetocin…CARBETOCIN (LV-101)LEVO THERAPEUTICS INCClosed
Aug 28, 2017A phase 2 study to evaluate efficacy, safety, and pharmacokinetics of glwl 01 in the treatment of patients with prader willi syndromeGLWL-01GLWL RESEARCH INCClosed

FDA Orphan Designations

Approved first, then open designations, newest first; 15 of 17
Mar 26, 2025Vykat XRtreatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS)Soleno Therapeutics, Inc.Approved
Jun 20, 2000GenotropinLong-term treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS).Pharmacia & UpjohnApproved
Apr 10, 2024celastroltreatment of Prader-Willi syndromeERX Pharmaceuticals, Inc.Designated
Feb 12, 2024pitolisantTreatment of Prader-Willi syndrome (PWS)Harmony Biosciences, LLCDesignated
Jan 30, 20245-BROMO-N-(PROP-2-YN-1-YL)-2-(1H-1,2,4-TRIAZOL-1-YL)…treatment of Prader-Willi syndromePalobiofarma S.L.Designated
May 16, 2023avasimibeTreatment of Prader-Willi syndromeEFIL BioScience Inc.Designated
Jan 3, 2023Cannabidiol acid methyl ester (CBDA-ME)Treatment of Prader-Willi SyndromeEPM Group Inc.Designated
Mar 1, 2022OxytocinTreatment of Prader-Willi SyndromeTonix Pharmaceuticals, Inc.Designated
Sep 2, 2021Synthetic analogue of cyclic Glycine-ProlineTreatment of Prader-Willi SyndromeNeuren Pharmaceuticals, Ltd.Designated
Mar 2, 2021Tesofensine plus metoprolol in a fixed-dose combinationTreatment of Prader-Willi SyndromeSaniona S/ADesignated
Oct 12, 2017synthetic cyclic 8 amino acid analog of human unacylated…Treatment of Prader-Willi syndrome (PWS)Millendo Therapeutics, Inc.Designated
Jun 15, 2017oxytocinTreatment of Prader-Willi syndromeEric Hollander, MDDesignated
Jun 8, 2017OleoylethanolamideTreatment of Prader-Willi syndromeNutriForward, LLCDesignated
Jan 19, 2017D-tagatoseTreatment of Prader-Willi SyndromeBiospherics.net LLCDesignated
Sep 21, 2015setmelanotideTreatment of Prader-Willi Syndrome.Rhythm Metabolics, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.